Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,646 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of the performance of multiple immunoassay diagnostic platforms on the National Microbiology Laboratory SARS-CoV-2 National Serology Panel.
Dibernardo A, Toledo NP, Robinson A, Osiowy C, Giles E, Day J, Robbin Lindsay L, Drebot MA, Booth TF, Pidduck T, Baily A, Charlton CL, Tipples G, Kanji JN, Brochu G, Lang A, Therrien C, Bélanger-Collard M, Beaulac SN, Gilfix BM, Boivin G, Hamelin MÈ, Carbonneau J, Lévesque S, Martin P, Finzi A, Gendron-Lepage G, Goyette G, Benlarbi M, Gasser R, Fortin C, Martel-Lafferrière V, Lavoie M, Guérin R, Haraoui LP, Renaud C, Jenkins C, O'Brien SF, Drews SJ, Conrod V, Tran V, Awrey B, Scheuermann R, DuPuis A, Payne A, Warszycki C, Girardin R, Lee W, Zahariadis G, Jiao L, Needle R, Cordenbach J, Zaharatos J, Taylor K, Teltscher M, Miller M, Elsherif M, Robertson P, Robinson JL. Dibernardo A, et al. Among authors: tran v. J Assoc Med Microbiol Infect Dis Can. 2022 Sep 27;7(3):186-195. doi: 10.3138/jammi-2021-0026. eCollection 2022 Sep. J Assoc Med Microbiol Infect Dis Can. 2022. PMID: 36337598 Free PMC article.
Practical guidance for clinical laboratories for SARS-CoV-2 serology testing.
Charlton C, Kanji J, Tran V, Kus J, Gubbay J, Osiowy C, Robinson J, Sekirov I, Drebot M, Hatchette T, Stein D, El-Gabalawy N, Lang A, Jiao L, Levett P, Wood H, Therrien C, Lindsay LR, Morshed M, Forbes J, Dibernardo A. Charlton C, et al. Among authors: tran v. Can Commun Dis Rep. 2021 May 7;47(4):171-183. doi: 10.14745/ccdr.v47i04a01. eCollection 2021 May 7. Can Commun Dis Rep. 2021. PMID: 34035663 Free PMC article. Review.
Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratories.
Stein DR, Osiowy C, Gretchen A, Thorlacius L, Fudge D, Lang A, Sekirov I, Morshed M, Levett PN, Tran V, Kus JV, Gubbay J, Mohan V, Charlton C, Kanji JN, Tipples G, Serhir B, Therrien C, Roger M, Jiao L, Zahariadis G, Needle R, Gilbert L, Desnoyers G, Garceau R, Bouhtiauy I, Longtin J, El-Gabalawy N, Dibernardo A, Lindsay LR, Drebot M; Canadian Public Health Laboratory Network (CPHLN) Serology Task Force. Stein DR, et al. Among authors: tran v. Diagn Microbiol Infect Dis. 2021 Nov;101(3):115412. doi: 10.1016/j.diagmicrobio.2021.115412. Epub 2021 Apr 24. Diagn Microbiol Infect Dis. 2021. PMID: 34425450 Free PMC article.
Characteristics of SARS-CoV-2 testing for rapid diagnosis of COVID-19 during the initial stages of a global pandemic.
Guthrie JL, Chen AJ, Budhram DR, Cronin K, Peci A, Nelson P, Mallo GV, Broukhanski G, Murti M, Majury A, Mazzulli T, Allen VG, Patel SN, Kus JV, Tran V, Gubbay JB. Guthrie JL, et al. Among authors: tran v. PLoS One. 2021 Jul 9;16(7):e0253941. doi: 10.1371/journal.pone.0253941. eCollection 2021. PLoS One. 2021. PMID: 34242243 Free PMC article.
Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis.
Yau K, Abe KT, Naimark D, Oliver MJ, Perl J, Leis JA, Bolotin S, Tran V, Mullin SI, Shadowitz E, Gonzalez A, Sukovic T, Garnham-Takaoka J, de Launay KQ, Takaoka A, Straus SE, McGeer AJ, Chan CT, Colwill K, Gingras AC, Hladunewich MA. Yau K, et al. Among authors: tran v. JAMA Netw Open. 2021 Sep 1;4(9):e2123622. doi: 10.1001/jamanetworkopen.2021.23622. JAMA Netw Open. 2021. PMID: 34473256 Free PMC article.
Assessment of population infection with SARS-CoV-2 in Ontario, Canada, March to June 2020.
Bolotin S, Tran V, Deeks SL, Peci A, Brown KA, Buchan SA, Ogbulafor K, Ramoutar T, Nguyen M, Thakkar R, DelaCruz R, Mustfa R, Maregmen J, Woods O, Krasna T, Cronin K, Osman S, Joh E, Allen VG. Bolotin S, et al. Among authors: tran v. Euro Surveill. 2021 Dec;26(50):2001559. doi: 10.2807/1560-7917.ES.2021.26.50.2001559. Euro Surveill. 2021. PMID: 34915969 Free PMC article.
Impact of coronavirus disease 2019 (COVID-19) pre-test probability on positive predictive value of high cycle threshold severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcription polymerase chain reaction (RT-PCR) test results.
Gubbay JB, Rilkoff H, Kristjanson HL, Forbes JD, Murti M, Eshaghi A, Broukhanski G, Corbeil A, Fittipaldi N, Hopkins JP, Kristjanson E, Kus JV, Macdonald L, Majury A, Mallo GV, Mazzulli T, Melano RG, Olsha R, Perusini SJ, Tran V, Allen VG, Patel SN. Gubbay JB, et al. Among authors: tran v. Infect Control Hosp Epidemiol. 2022 Sep;43(9):1179-1183. doi: 10.1017/ice.2021.369. Epub 2021 Aug 9. Infect Control Hosp Epidemiol. 2022. PMID: 34369325 Free PMC article.
1,646 results